Evidence map›Paper›PMID 33908295›Full record

Trial reportJournal of psychopharmacology (Oxford, England)2021

Hydrocortisone as an adjunct to brief cognitive-behavioural therapy for specific fear: Endocrine and cognitive biomarkers as predictors of symptom improvement.

Susann Steudte-Schmiedgen, Emily Fay, Liliana Capitao, Clemens Kirschbaum, Andrea Reinecke

Open access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of psychopharmacology (Oxford, England), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Susann Steudte-SchmiedgenDepartment of Psychotherapy and Psychosomatic Medicine, Technische Universität Dresden, Dresden, Germany.ORCID https://orcid.org/0000-0002-1171-7133
Emily FayDepartment of Psychiatry, University of Oxford, Oxford, UK.ORCID https://orcid.org/0000-0002-0133-8420
Liliana CapitaoDepartment of Psychiatry, University of Oxford, Oxford, UK.ORCID https://orcid.org/0000-0003-3117-5156
Clemens KirschbaumFaculty of Psychology, Technische Universität Dresden, Dresden, Germany.
Andrea ReineckeDepartment of Psychiatry, University of Oxford, Oxford, UK.
University of Oxford · GBOxford Health NHS Foundation Trust · GBTechnische Universität Dresden · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGlucocorticoid (GC) administration prior to exposure-based cognitive-behavioural therapy (CBT) has emerged as a promising approach to facilitate treatment outcome in anxiety disorders. Further components relevant for improved CBT efficacy include raised

aimsTo investigate hydrocortisone as an adjunct to CBT for spider fear and the modulating role of threat bias change and endogenous short-term and long-term GCs for treatment response.

methodsSpider-fearful individuals were randomized to receiving either 20 mg of hydrocortisone ( RESULTS/OUTCOMES: Self-report, behavioural and threat processing indices improved following CBT. Hydrocortisone augmentation resulted in greater improvement of self-report spider fear and stronger increase in speed when approaching a spider, but not on threat bias. Neither threat bias nor endogenous GCs predicted symptom change, and no interactive effects with hydrocortisone emerged. Preliminary evidence indicated higher hair cortisone as predictor of a stronger threat bias reduction. CONCLUSIONS/

interpretationOur data extend earlier findings by suggesting that GC administration boosts the success of exposure therapy for specific fear even with a low-level therapist involvement. Future studies corroborating our result of a predictive hair GC relationship with threat bias change in larger clinical samples are needed.

Indexed as

AdolescentAdultAnimalsBiomarkersCognitive Behavioral TherapyCombined Modality TherapyDouble-Blind MethodFemaleFollow-Up StudiesGlucocorticoidsHumansHydrocortisoneImplosive TherapyMalePhobic DisordersSpidersBiomarkersGlucocorticoidsHydrocortisoneCognitive-behaviour therapyglucocorticoidshydrocortisonespecific phobiathreat processing

Identifiers

PMID33908295
PMCPMC8278554
OpenAlexW3133301240

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.